Clinical Trial

The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this pilot study is to explore a combination of two interventions: (1) a behavioral alcohol-reduction intervention using motivational interviewing, and (2) a blinded probiotic microbiome or placebo intervention. The study examines whether these interventions improve cognitive and neurophysiological function, including brain metabolism, in older adults who are high-risk alcohol drinkers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-09.
Status change: Not Yet Recruiting → Recruiting 2026-03-03
Trial Details
NCT Number NCT07415707
Lead Sponsor University of Miami
Collaborators: Exegi Pharma
Conditions Aging, Alcohol Drinking
Enrollment 20 participants
Start Date 2026-02-26
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-04